**3. Conclusions**

Patients' quality of life is greatly affected by bone metastases. Therefore, prevention and treatment of skeletal metastases require new strategies. New therapeutic strategies can be expected as our understanding of bone metastases evolves. It is possible to further reduce the clinical burden of metastatic bone disease by combining bone-targeted therapies.

*Palliative Therapy of Bone Metastases DOI: http://dx.doi.org/10.5772/intechopen.107895*
